Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 240

1.

North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.

Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH.

J Nerv Ment Dis. 2015 May;203(5):328-35. doi: 10.1097/NMD.0000000000000290.

PMID:
25919383
2.

Core Schemas in Youth at Clinical High Risk for Psychosis.

Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J.

Behav Cogn Psychother. 2015 Apr 21:1-11. [Epub ahead of print]

PMID:
25896713
3.

Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study.

Gee DG, McEwen SC, Forsyth JK, Haut KM, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Constable T, Cannon TD.

Hum Brain Mapp. 2015 Mar 28. doi: 10.1002/hbm.22791. [Epub ahead of print]

PMID:
25821147
4.

Substance use in individuals at clinical high risk of psychosis.

Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J.

Psychol Med. 2015 Mar 2:1-10. [Epub ahead of print]

PMID:
25727300
5.

First-Episode Services for Psychotic Disorders in the U.S. Public Sector: A Pragmatic Randomized Controlled Trial.

Srihari VH, Tek C, Kucukgoncu S, Phutane VH, Breitborde NJ, Pollard J, Ozkan B, Saksa J, Walsh BC, Woods SW.

Psychiatr Serv. 2015 Feb 2:appips201400236. [Epub ahead of print]

PMID:
25639994
6.

Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients.

Hay RA, Roach BJ, Srihari VH, Woods SW, Ford JM, Mathalon DH.

Biol Psychol. 2015 Feb;105:130-7. doi: 10.1016/j.biopsycho.2015.01.004. Epub 2015 Jan 17.

PMID:
25603283
7.

Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.

Auther AM, Cadenhead KS, Carrión RE, Addington J, Bearden CE, Cannon TD, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Cornblatt BA.

Acta Psychiatr Scand. 2015 Jan 9. doi: 10.1111/acps.12382. [Epub ahead of print]

PMID:
25572323
8.

Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study.

Srihari VH, Tek C, Pollard J, Zimmet S, Keat J, Cahill JD, Kucukgoncu S, Walsh BC, Li F, Gueorguieva R, Levine N, Mesholam-Gately RI, Friedman-Yakoobian M, Seidman LJ, Keshavan MS, McGlashan TH, Woods SW.

BMC Psychiatry. 2014 Dec 4;14(1):335. doi: 10.1186/s12888-014-0335-3.

9.

Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS).

Trotman HD, Holtzman CW, Walker EF, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH.

Schizophr Res. 2014 Dec;160(1-3):104-9. doi: 10.1016/j.schres.2014.09.017. Epub 2014 Nov 7.

PMID:
25443665
10.

Movement abnormalities predict transitioning to psychosis in individuals at clinical high risk for psychosis.

Callaway DA, Perkins DO, Woods SW, Liu L, Addington J.

Schizophr Res. 2014 Nov;159(2-3):263-6. doi: 10.1016/j.schres.2014.09.031. Epub 2014 Oct 11.

PMID:
25311779
11.

Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project.

Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R.

Schizophr Bull. 2015 Mar;41(2):419-28. doi: 10.1093/schbul/sbu099. Epub 2014 Aug 6.

12.

The content of attenuated psychotic symptoms in those at clinical high risk for psychosis.

Marshall C, Denny E, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker E, Addington J.

Psychiatry Res. 2014 Nov 30;219(3):506-12. doi: 10.1016/j.psychres.2014.06.023. Epub 2014 Jun 21.

PMID:
25048759
13.

Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.

Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R; North American Prodrome Longitudinal Study Consortium.

Biol Psychiatry. 2015 Jan 15;77(2):147-57. doi: 10.1016/j.biopsych.2014.05.023. Epub 2014 Jun 12.

PMID:
25034946
14.

Current status specifiers for patients at clinical high risk for psychosis.

Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH.

Schizophr Res. 2014 Sep;158(1-3):69-75. doi: 10.1016/j.schres.2014.06.022. Epub 2014 Jul 8.

15.

Personal Beliefs about Experiences in those at Clinical High Risk for Psychosis.

Stowkowy J, Perkins DO, Woods SW, Nyman K, Addington J.

Behav Cogn Psychother. 2014 Jun 20:1-7. [Epub ahead of print]

PMID:
24949991
16.

Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis.

Buchy L, Perkins D, Woods SW, Liu L, Addington J.

Schizophr Res. 2014 Jul;156(2-3):277-80. doi: 10.1016/j.schres.2014.04.021. Epub 2014 May 14.

PMID:
24837058
17.

Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis.

Yong E, Barbato M, Penn DL, Keefe RS, Woods SW, Perkins DO, Addington J.

Psychiatry Res. 2014 Aug 15;218(1-2):39-43. doi: 10.1016/j.psychres.2014.04.003. Epub 2014 Apr 12.

PMID:
24755041
18.

Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study.

Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos HW, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD.

Neuroimage. 2014 Aug 15;97:41-52. doi: 10.1016/j.neuroimage.2014.04.027. Epub 2014 Apr 13.

PMID:
24736173
19.

Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.

Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS.

Early Interv Psychiatry. 2014 Feb 27. doi: 10.1111/eip.12128. [Epub ahead of print]

PMID:
24576057
20.

The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.

Meyer EC, Carrión RE, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Heinssen R, Seidman LJ; NAPLS group.

Schizophr Bull. 2014 Nov;40(6):1452-61. doi: 10.1093/schbul/sbt235. Epub 2014 Feb 18.

PMID:
24550526
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk